Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.10.0.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses:        
Research and development $ 1,788 $ 2,000 $ 14,981 $ 2,580
General and administrative 820 848 2,733 2,516
Loss from operations (2,608) (2,848) (17,714) (5,096)
Interest income (13) (6) (85) (6)
Interest expense 0 106 0 294
Interest expense - related party 0 0 0 81
Change in fair value of convertible notes payable 0 0 0 99
Change in fair value of warrant liabilities 0 0 0 451
Net Loss $ (2,595) $ (2,948) $ (17,629) $ (6,015)
Net loss per common share outstanding, basic and diluted $ (0.25) $ (0.30) $ (1.73) $ (1.09)
Weighted average number of common shares outstanding, basic and diluted 10,295,958 9,972,663 10,216,466 5,514,988